A COST-EFFECTIVENESS MODEL OF BAZEDOXIFENE VS. RALOXIFENE FOR THE PREVENTION OF FRACTURES IN SPANISH POSTMENOPAUSAL WOMEN

被引：0
|
作者：
Darba, Josep [1 ]
Perez-Alvarez, Nuria [2 ]
Kaskens, Lisette [2 ]
Racketa, Jill [3 ]
Rejas, Javier [4 ]
机构：
[1] Univ Barcelona, E-08007 Barcelona, Spain
[2] BCN Hlth Econ & Outcomes Res, Barcelona, Spain
[3] Pfizer Inc, New York, NY USA
[4] Pfizer Inc, Hlth Econ & Outcomes Res Dept, Madrid, Spain
来源：
OSTEOPOROSIS INTERNATIONAL | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：256 / 257
页数：2
相关论文
共 50 条
  • [41] Ranibizumab vs. pegaptanib: a cost-effectiveness study?
    Viroj Wiwanitkit
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2010, 248 : 1675 - 1675
  • [42] Cost-Effectiveness of Detoxification vs. Methadone in Pregnancy
    Seymour-Willey, Alicia
    Sargent, James
    Toffey, David E.
    Caughey, Aaron B.
    OBSTETRICS AND GYNECOLOGY, 2018, 131 : 74S - 74S
  • [43] Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia
    Meadows E.S.
    Klein R.
    Rousculp M.D.
    Smolen L.
    Ohsfeldt R.L.
    Johnston J.A.
    BMC Women's Health, 7 (1)
  • [44] Cost-effectiveness of risedronate therapy in postmenopausal women with varying risk of osteoporotic fractures: A Swiss analysis
    Lamy, O
    Krieg, M
    Wasserfalllen, J
    Greiner, R
    Russ, W
    BONE, 2005, 36 : S411 - S411
  • [45] Cost-effectiveness of alendronate in the treatment of postmenopausal women in the UK
    Borgström, F
    Johnell, O
    Jönsson, B
    Kanis, J
    Kong, SX
    Sen, SS
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S13 - S13
  • [46] Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women
    Schousboe, JT
    Nyman, JA
    Kane, RL
    Ensrud, KE
    ANNALS OF INTERNAL MEDICINE, 2005, 142 (09) : 734 - 741
  • [47] COST-EFFECTIVENESS OF ABALOPARATIDE FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Hansson-Hedblom, A.
    Geale, K.
    Borgstrom, F.
    Johansson, H.
    Fitzpatrick, L.
    Kanis, J. A.
    VALUE IN HEALTH, 2018, 21 : S197 - S197
  • [48] Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporotic women
    Hiligsmann, Mickael
    Boonen, Annelies
    Dirksen, Carmen D.
    Ben Sedrine, Wafa
    Reginster, Jean-Yves
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2013, 13 (01) : 19 - 28
  • [49] COST-EFFECTIVENESS OF ABALOPARATIDE FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Hiligsmann, M.
    Williams, S. A.
    Fitzpatrick, L. A.
    Reginster, J. -Y.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S50 - S51
  • [50] The cost-effectiveness of osteoporosis screening strategies for postmenopausal women
    Nayak, S.
    Greenspan, S. L.
    Liu, H.
    Michaud, K.
    Owens, D. K.
    Roberts, M. S.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 : 410 - 411
12345